Type of Surgery | Ā | Ā | Ā | Ā |
āTransoral Laser | 28 (66.7%) | 6 (26.1%) | 21 (65.6%) | <0.0001 |
āTransoral Bovie | 9 (21.4%) | 1 (4.3%) | 10 (31.3%) | |
āOther* | 5 (11.9%) | 16 (69.6%) | 1 (3.1%) | |
Margins | Ā | Ā | Ā | Ā |
āPositive | 4 (10.0%) | 3 (13.6%) | 4 (13.8%) | 0.85 |
āNegative orā<ā5Ā mm | 36 (90.0%) | 19 (86.4%) | 25 (86.2%) | |
Chemotherapy | Ā | Ā | Ā | Ā |
āYes | 12 (28.6%) | 14 (56.0%) | 20 (62.5%) | 0.0050 |
āNo | 30 (71.4%) | 9 (44.0%) | 12 (37.5%) | |
Time from Surgery to Completion of RT (days) | Ā | Ā | Ā | Ā |
āMedian (range) | 91 (74 ā 135) | 107 (85 ā 140) | 92 (81 ā 144) | 0.0008 |
Duration of feeding tube (mo) | Ā | Ā | Ā | Ā |
āMedian (range) | N/A | 7.27 (3.91 ā 40.53) | 5.1 (1.68 ā 22.96) | 0.069 |
Was feeding tube permanent? | Ā | Ā | Ā | Ā |
āYes | N/A | 12 (52.2%) | 5 (16.1%) | 0.0075 |
āNo | N/A | 11 (47.8%) | 26 (83.9%) | |
Cause of Death | Ā | Ā | Ā | Ā |
āLocoregional Disease | 0 (0%) | 2 (15.4%) | 0 (0%) | 0.36 |
āDistant Metastatic Disease | 3 (60%) | 1 (7.7%) | 2 (33.3%) | |
āSecond Primary | 1 (20%) | 5 (38.5%) | 3 (50%) | |
āAll Other Causes | 1 (20%) | 5 (38.5%) | 1 (16.7%) |